FA
NPTN

Friess Associates’s NEOPHOTONICS CORP NPTN Stock Holding History

Friess Associates’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-586,126
Closed -$5.98M – 114
2021
Q2 		$5.98M Buy
586,126
+34,492
+6% +$364K 2.26% 13
2021
Q1 		$6.59M Buy
+551,634
New +$6.25M 2.56% 7
2016
Q3 		– Sell
-58,000
Closed -$553K – 164
2016
Q2 		$553K Hold
58,000
– – 0.06% 102
2016
Q1 		$814K Buy
+58,000
New +$600K 0.08% 86
2015
Q3 		– Sell
-61,100
Closed -$558K – 183
2015
Q2 		$558K Buy
+61,100
New +$463K 0.05% 109
2014
Q2 		– Sell
-70,000
Closed -$555K – 174
2014
Q1 		$555K Buy
+70,000
New +$521K 0.04% 90

Other funds holding NPTN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Friess Associates's NPTN Position: Q3 2021 in Review

Friess Associates sold out of NEOPHOTONICS CORP (NPTN) in Q3 2021, closing a stake of 586,126 shares — an estimated $5.98M sold.

Friess Associates first reported a position in NPTN in Q1 2014 and held it in 6 quarters. The position peaked at $6.59M in Q1 2021. 124 funds tracked by Wall St. Rank hold NPTN as of Q3 2021.

  • Friess Associates reported no remaining NEOPHOTONICS CORP position as of Q3 2021 after selling out during the quarter.
  • Friess Associates sold 586,126 NEOPHOTONICS CORP shares in Q3 2021, an estimated $5.98M.
  • Friess Associates first reported a position in NEOPHOTONICS CORP in Q1 2014 and held it in 6 quarters.
  • Friess Associates's NEOPHOTONICS CORP position peaked at $6.59M in Q1 2021.
  • 124 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2021.

Based on Friess Associates's 13F filing for Q3 2021, filed 12 Nov 2021.